Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Surgeon Implant Training, Patient Consent Materials Sought By Panel

This article was originally published in The Gray Sheet

Executive Summary

Approval conditions recommended by FDA's General & Plastic Surgery Devices Panel emphasize patient consent as critical to fostering informed decisions by consumers of Inamed's silicone breast implants

You may also be interested in...



Inamed Silicone Implant Patient Monitoring Plans Allay Rupture Concerns

Inamed's proposal to closely follow patients implanted with silicone gel-filled breast prostheses helped sway FDA's General & Plastic Surgery Devices Panel to recommend conditional approval of the firm's PMA by a 9-6 margin

Inamed Silicone Implant Patient Monitoring Plans Allay Rupture Concerns

Inamed's proposal to closely follow patients implanted with silicone gel-filled breast prostheses helped sway FDA's General & Plastic Surgery Devices Panel to recommend conditional approval of the firm's PMA by a 9-6 margin

Anti-Silicone Implant Media Campaign, Rally Planned By Consumer Groups

A petition from Public Citizen appears to have persuaded FDA to disclose the General & Plastic Surgery Devices Panel roster nearly two weeks before the panel's review of a silicone gel breast implant premarket application

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019200

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel